Zai Lab (ZLAB) Competitors $26.32 -1.70 (-6.07%) Closing price 04:00 PM EasternExtended Trading$26.56 +0.24 (+0.91%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZLAB vs. ASND, RDY, VTRS, ROIV, BBIO, MRNA, QGEN, ELAN, VRNA, and RVMDShould you be buying Zai Lab stock or one of its competitors? The main competitors of Zai Lab include Ascendis Pharma A/S (ASND), Dr. Reddy's Laboratories (RDY), Viatris (VTRS), Roivant Sciences (ROIV), BridgeBio Pharma (BBIO), Moderna (MRNA), QIAGEN (QGEN), Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), and Revolution Medicines (RVMD). These companies are all part of the "pharmaceutical products" industry. Zai Lab vs. Its Competitors Ascendis Pharma A/S Dr. Reddy's Laboratories Viatris Roivant Sciences BridgeBio Pharma Moderna QIAGEN Elanco Animal Health Verona Pharma PLC American Depositary Share Revolution Medicines Ascendis Pharma A/S (NASDAQ:ASND) and Zai Lab (NASDAQ:ZLAB) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends. Does the media favor ASND or ZLAB? In the previous week, Ascendis Pharma A/S had 2 more articles in the media than Zai Lab. MarketBeat recorded 10 mentions for Ascendis Pharma A/S and 8 mentions for Zai Lab. Ascendis Pharma A/S's average media sentiment score of 0.50 beat Zai Lab's score of -0.12 indicating that Ascendis Pharma A/S is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ascendis Pharma A/S 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Zai Lab 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders believe in ASND or ZLAB? 41.7% of Zai Lab shares are held by institutional investors. 40.0% of Ascendis Pharma A/S shares are held by company insiders. Comparatively, 5.0% of Zai Lab shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is ASND or ZLAB more profitable? Zai Lab has a net margin of -49.68% compared to Ascendis Pharma A/S's net margin of -54.94%. Ascendis Pharma A/S's return on equity of 0.00% beat Zai Lab's return on equity.Company Net Margins Return on Equity Return on Assets Ascendis Pharma A/S-54.94% N/A -24.31% Zai Lab -49.68%-27.32%-18.85% Which has more volatility & risk, ASND or ZLAB? Ascendis Pharma A/S has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Comparatively, Zai Lab has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Do analysts rate ASND or ZLAB? Ascendis Pharma A/S currently has a consensus price target of $249.80, suggesting a potential upside of 23.66%. Zai Lab has a consensus price target of $56.35, suggesting a potential upside of 114.10%. Given Zai Lab's higher probable upside, analysts clearly believe Zai Lab is more favorable than Ascendis Pharma A/S.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ascendis Pharma A/S 1 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 1 Strong Buy rating(s) 2.94Zai Lab 1 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.63 Which has higher earnings and valuation, ASND or ZLAB? Zai Lab has lower revenue, but higher earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than Zai Lab, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAscendis Pharma A/S$490.75M25.39-$409.12M-$5.16-39.15Zai Lab$427.80M6.88-$257.10M-$2.04-12.90 SummaryAscendis Pharma A/S beats Zai Lab on 9 of the 17 factors compared between the two stocks. Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZLAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZLAB vs. The Competition Export to ExcelMetricZai LabMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.13B$3.45B$6.19B$10.68BDividend YieldN/A2.26%5.71%4.82%P/E Ratio-12.9023.4529.9129.71Price / Sales6.88494.28590.38132.28Price / CashN/A45.5737.0161.44Price / Book3.4310.4012.046.60Net Income-$257.10M-$52.62M$3.32B$276.82M7 Day Performance-6.96%2.08%1.79%2.07%1 Month Performance-18.99%10.84%6.28%2.62%1 Year Performance-20.68%13.57%61.13%32.86% Zai Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZLABZai Lab2.6008 of 5 stars$26.32-6.1%$56.35+114.1%-3.2%$3.13B$427.80M-12.901,869News CoverageAnalyst ForecastAnalyst RevisionASNDAscendis Pharma A/S3.0078 of 5 stars$208.43-0.5%$248.29+19.1%+57.4%$12.93B$393.54M-40.391,017Analyst ForecastGap UpRDYDr. Reddy's Laboratories2.6155 of 5 stars$14.36+0.1%$16.95+18.1%-6.5%$11.97B$3.81B21.7527,811News CoveragePositive NewsEarnings ReportAnalyst ForecastGap UpVTRSViatris3.1848 of 5 stars$9.86+1.2%$10.40+5.5%-10.7%$11.36B$14.74B-3.4032,000Analyst ForecastROIVRoivant Sciences2.6451 of 5 stars$16.21+1.1%$19.94+23.0%+55.9%$10.95B$29.05M-23.16860BBIOBridgeBio Pharma4.6084 of 5 stars$55.96+0.8%$63.94+14.3%+120.1%$10.61B$221.90M-13.68400News CoverageAnalyst ForecastMRNAModerna4.2736 of 5 stars$26.74-0.3%$41.81+56.4%-50.8%$10.48B$3.24B-3.555,800Trending NewsAnalyst ForecastQGENQIAGEN3.9631 of 5 stars$47.30+1.0%$49.40+4.4%+20.6%$10.41B$1.98B27.955,765Positive NewsELANElanco Animal Health2.7906 of 5 stars$20.04+1.4%$19.14-4.5%+74.0%$9.82B$4.44B23.309,000News CoverageAnalyst ForecastVRNAVerona Pharma PLC American Depositary Share1.0849 of 5 stars$106.91flat$109.00+2.0%N/A$9.21B$42.28M-107.9930Positive NewsRVMDRevolution Medicines4.3312 of 5 stars$48.75+1.1%$74.64+53.1%+10.2%$9.02B$11.58M-10.83250Analyst Forecast Related Companies and Tools Related Companies Ascendis Pharma A/S Alternatives Dr. Reddy's Laboratories Alternatives Viatris Alternatives Roivant Sciences Alternatives BridgeBio Pharma Alternatives Moderna Alternatives QIAGEN Alternatives Elanco Animal Health Alternatives Verona Pharma PLC American Depositary Share Alternatives Revolution Medicines Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZLAB) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrade this between 9:30 and 10:45 am ESTIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredBitcoin is dead?Bitcoin’s historic run may be ending — and Weiss Ratings’ Juan Villaverde, who’s nailed every major crypto bul...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zai Lab Limited Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Zai Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
